Kelyniam Global reports Q3 results
Source: SeekingAlpha
2025-11-10 17:00:26 ET
More on Kelyniam Global
Read the full article on Seeking Alpha
For further details see:
Kelyniam Global reports Q3 results
Kelyniam Global Inc
NASDAQ: KLYG
KLYG Trading
26.92% G/L:
$0.1155 Last:
100 Volume:
$0.11545 Open:
KLYG Latest News
November 13, 2025 12:47:51 pm
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 06, 2025 07:09:37 pm
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
September 18, 2025 11:23:00 am
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion(TM) BCP-PEEK Implant
KLYG Stock Data
$7,065,972
29,970,000
N/A
1
N/A
Medical Equipment & Supplies
Healthcare
US
Little Rock
